Navigation Links
Wound Management Technologies, Inc. Announced Today That It Has Reached an Agreement in Principal to Acquire BioPharma Management Technologies, Inc.
Date:6/16/2009

chnology company that recently launched the development proprietary technologies and associated product applications for topical pain management and resorbable orthoses.

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events. 

    For Further Information:
    Product Information                  Shareholder Relations
    Cathy Bradshaw                       Lucy Singleton
    President                            Secretary
    954-315-9242                         817-820-7080


'/>"/>
SOURCE Wound Management Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Hill-Rom Innovative Envision(R) E700 Wound Surface Receives Gold Medical Device Excellence Award
2. NeoStem Obtains Exclusive Worldwide License for Innovative Stem Cell Technology and Applications to Heal Chronic Wounds
3. ULURU to Present Clinical Evidence and Advanced Research on Altrazeal at the Society for Advance Wound Care Conference for 2009
4. Environmental Tectonics Corporation Exhibiting at the Annual Symposium on Advanced Wound Care and Wound Healing Society
5. Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher
6. WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research
7. Environmental Tectonics Corporation Announces Placement of Two Monoplace Chambers at St. John Wound Center; First Computer-controlled Hyperbaric Chambers in Oklahoma
8. Wound Management Technologies, Inc. Announces a Published Case Study
9. Advanced Viral Announces Phase IIb Wound Healing Trial for AVR123
10. Derma Sciences Announces Multiple Clinical Posters Featuring MEDIHONEY(R) and ALGICELL Ag(R) to be Presented at Upcoming Wound Care Conference
11. Glycotex Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... , - ... the Ability of,Cardiopoietic Cells to Restore Cardiac Function ... leading Belgian biotechnology company specialising,in cell-based therapies for ... has completed, two months ahead of schedule,enrolment in ... trial of C-Cure, a,unique stem cell therapy for ...
(Date:12/14/2009)... Joins with State Biotech Leaders to Develop ... and Development while Boosting Rhode Island,s Growing ... PROVIDENCE, R.I., Dec. 14 Several ... research, medicine and biotechnology gathered today at ... the importance of medical innovation in Rhode ...
(Date:12/14/2009)... Mass., Dec. 14 Decision Resources, one ... for pharmaceutical and healthcare issues, finds that, owing ... atrial fibrillation drug market will increase more than ... billion in 2018 in the United States, France, ... ,, The new Pharmacor report entitled Atrial ...
(Date:12/11/2009)... December 10, 2009 miRagen Therapeutics, Inc., a ... developing innovative microRNA-based therapeutics for cardiovascular and muscle ... that microRNA-206 (miR-206) plays a crucial role in ... Lou Gehrig,s disease) and in neuromuscular synaptic regeneration ... December 11 issue of the journal Science ...
Breaking Biology Technology:Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2
... New Senior Management Appointments Strengthen Executive Team, ... a,privately held pharmaceutical company developing a novel transdermal,delivery ... the,company as chair and CEO. The company also ... including Don Brown, chief,operating officer and president; John ...
... (OTC Bulletin Board: BOVD) ("Boveran") today announced its ... majority interest in Sophora,Diagnostic Lab, Inc., a New ... the LOI, Dr. Mikhail Kantius will join Boveran ... Lab operations and,Business Development for pathology lab services., ...
... International,Inc. (Nasdaq: CHDX ), a leading independent American provider ... China, today,announced that the Company will appear at the following ... held at the Grand Hyatt Hotel ... available for this event. -- ...
Other Biology Technology:Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO 2Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO 3Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO 4Boveran Diagnostics, Inc. Announces Planned Acquisition of New York-Based Pathology Lab: Sophora Diagnostic Lab, Inc. 2Chindex International, Inc. Announces Appearances at Upcoming Investor Conferences 2Chindex International, Inc. Announces Appearances at Upcoming Investor Conferences 3
(Date:12/15/2009)... release is available in German . , ... in predicting the future distribution of mammals. This is ... of 140 indigenous European mammals. The researchers analysed data ... well as the phylogenetic information of the species. Judging ... closely related species, mammals seem to adapt fast to ...
(Date:12/14/2009)... part of an international team that has used DNA ... the history of North America,s woolly mammoths and ancient ... and Atmospheric Sciences professor Duane Froese and his colleagues ... of bones and teeth. That analysis concluded that more ... (the ,megafauna,) disappeared about 13,000 years ago. , ...
(Date:12/14/2009)... founded a new journal Cardiovascular Engineering and Technology ... a forum for research on all aspects of cardiovascular ... the new quarterly journal will appear in March 2010 ... Annals of Biomedical Engineering and Cellular and ... will present a wide spectrum of research, from ...
Breaking Biology News(10 mins):Species distribution models are of only limited value for predicting future mammal distributions 2Biomedical Engineering Society's new journal to be published by Springer 2MIT 3A Muscle synergies may be key to stroke treatment 59833 1MIT 3A Muscle synergies may be key to stroke treatment 59833 2Media source impacts ag biotech communication 10439 1Media source impacts ag biotech communication 10439 2Researchers find ways to encourage spinal cord regeneration after injury 10437 1Researchers find ways to encourage spinal cord regeneration after injury 10437 2
... / ST. PAUL (April 2, 2008) It appears ... concentration of African Americans is associated with greater alcohol ... to a recent study by University of Minnesota researchers. ... high concentrations of African Americans had higher homicide rates ...
... responsible for spreading disease are increasingly becoming resistant to ... access journal BMC Complementary and Alternative Medicine suggests that ... villosum (S villosum), have potential for keeping mosquitoes at ... nightshade family known for its medicinal properties and ...
... crawl into crevices than swim, and that may be able ... represent an entirely unknown family of fishes, says a University ... off Ambon Island, has tan- and peach-colored zebra-striping, and rippling ... like a glass sculpture that Dale Chihuly might have dreamed ...
Other Biology News:Alcohol and malt liquor availability and promotion higher in African American inner cities 2Ayurvedic nightshade deadly for dengue mosquito 2New fish has a face even Dale Chihuly could love 2New fish has a face even Dale Chihuly could love 3
... (PI) is a fluorescent nucleic acid dye ... As a nuclear counterstain, propidium iodide ... in color. The fluorescent red color ... fluorochromes such as FITC, Cy2 or AMCA. ...
... simultaneous dual parameter assay for mitochondrial ... activity. Active caspases are detected by ... which are cell-permeable, non-cytotoxic and bind ... the cells. At the same time ...
... DMEM and harvested at the log phase of ... in their native forms, cells were fixed in ... 12-well (5 mm) adhesive coated slide, with each ... and to minimize background staining. Each well ...
... The CopyControl™ vector can be induced ... These vectors provide the stability of single-copy ... cosmids or other cloning vectors. The kits ... (ligation reagents, insert size screening system) necessary ...
Biology Products: